210
Views
40
CrossRef citations to date
0
Altmetric
Functional Disorders

Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable?

, , , , , , , , , , & show all
Pages 567-572 | Received 14 Nov 2009, Accepted 03 Jan 2010, Published online: 22 Apr 2010

References

  • Talley NJ. Scope of the problem of functional digestive disorders. Eur J Surg 1998;582:35–41.
  • Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: population-based study in Olmsted Country, Minnesota. Gastroenterology 1997;112:1448–56.
  • Manabe N, Haruma K, Hata J, Kusunoki H, Kamada T. Changes in upper gastrointestinal symptoms and endoscopic findings in Japan during the past 15 years. Gastroenterology 2007;132:A344.
  • Okumura T, Tanno S, Ohhira M, Tanno S. Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 2009; Epub ahead of print.
  • Nakajima S. The specta of functional gastrointestinal disorders (FGID) in a Japanese hospital outpatient department according to the ROME II Integrative Questionnaire. J Gastroenterol Hepatol 2008;23 Suppl 2:S186–92.
  • Nakao H, Konishi H, Mitsufuji S, Yamaguchi J, Yasu T, Taniguchi J, Comparison of clinical features and patient background in functional dyspepsia and peptic ulcer. Dig Dis Sci 2007;52:2152–8.
  • Geeraerts B, Tack J. Functional dyspepsia: past, present, and future. J Gastroenterol 2008;43:251–5.
  • Drossman DA. The gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377–90.
  • Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370–6.
  • Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN study. Am J Gastroenterol 2005;100:1477–88.
  • Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85–92.
  • Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29–34.
  • Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther 2007;26:453–61.
  • Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Functional gastroduodenal disorders. Gastroenterology 2006;130:1466–79.
  • Crean GP, Holden RJ, Knill-Jones RP, Beattie AD, James WB, Marjoribanks FM, A database on dyspepsia. Gut 1994;35:191–202.
  • Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the population: overlap and lack of stability over time. Gastroenterology 1995;109:671–80.
  • Talley NJ, Weaver AL, Zinmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165–77.
  • Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, The prevalence of clinical significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003;17:1481–91.
  • Roder DM. The epidemiology of gastric cancer. Gastric Cancer 2002;5:5–11.
  • Tsukumo H. Values estimated by the Population-based Cancer Registry Group. Annual report of Ministry of Health, Labour and Welfare, Japan. 2002;24–49.
  • Savarino E, Pohl D, Zentilin P, Dulbecco P, Sammito G, Sconfienza L, Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut 2009;58:1185–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.